Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026, held in Madrid Oct. 23–27.

Omega-3 EPA linked to longer survival after surgery for colorectal cancer liver metastases

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Monday 26 October →